RonanJKellyMDMBA
Oncology • Dallas, TXGastrointestinal Cancer, Thoracic Cancer
Director of the Charles A. Sammons Cancer Center and W.W. Caruth Jr. Endowed Chair of Immunology at Baylor University Medical Center Chief of Oncology Baylor Scott & White Health System (NTx) Clinical Professor Texas A&M University Adjunct Associate Professor of Oncology Johns Hopkins Professor Clinical Sciences Division at the Translational Genomics Research Institute (TGEN), Phoenix, Arizona
Dr. Kelly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Charles A. Sammons Cancer Center at Baylor University Medical Center
3410 Worth Street, Suite 550
Dallas, TX 75246Phone+1 214-820-2881Fax+1 214-820-2846- Is this information wrong?
Summary
- Dr. Ronan Kelly is an oncologist in Dallas, TX and is the Director of the Charles A. Sammons Cancer Center at Baylor University Medical Center. He received his medical degree from The Royal College of Surgeons Ireland and has been in practice for over 20 years. He specializes in thoracic malignancies most notably esophageal, gastroesophageal junction, gastric, lung cancers, mesothelioma and thymic malignancies. He remains an adjunct associate professor of oncology at Johns Hopkins and is a clinical professor at Texas A&M University and at the Translational Genomics Research Institute (TGEN) in Phoenix AZ. He is the founder and director of the Texas ImmunoOncology Biorepository (TIOB) and is extensively published in major peer reviewed medical journals.
Education & Training
University College DublinMBA, 2000 - 2001
Royal College of Surgeons IrelandClass of 1998, MB Bch
Certifications & Licensure
TX State Medical License 2018 - 2024
MD State Medical License 2011 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- The Royal College of Physicians in IrelandMember
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- CHFR Methylation Status Esophageal Cancer Study Start of enrollment: 2011 Jun 01
- Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC) Start of enrollment: 2013 Jul 26
- Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer Start of enrollment: 2013 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsNeoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses.Ronan J Kelly, Blair V Landon, Ali H Zaidi, Dipika Singh, Jenna V Canzoniero, Archana Balan, Russell K Hales, K Ranh Voong, Richard J Battafarano, Blair A Jobe, Stephe...> ;Nature Medicine. 2024 Mar 19
- Sitravatinib combined with PD-1 blockade enhances cytotoxic T-cell infiltration by M2 to M1 tumor macrophage repolarization in esophageal adenocarcinoma.Ryan Sweeney, Ashten N Omstead, John T Fitzpatrick, Ping Zheng, Anastasia Gorbunova, Erin E Grayhack, Arul Goel, Alisha F Khan, Juliann E Kosovec, Patrick L Wagner, Bl...> ;Carcinogenesis. 2024 Apr 12
- Role of Immunotherapy in Gastroesophageal Cancers-Advances, Challenges and Future Strategies.Emer Lynch, Austin G Duffy, Ronan J Kelly> ;Cancers. 2023 Nov 14
- Join now to see all
Lectures
- Safety and efficacy of durvalumab in combination with tremelimumab, durvalumab monotherapy, and tremelimumab monotherapy in patients with advanced gastric cancer.2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
- Induction nivolumab or nivolumab/ipilimumab prior to concurrent chemoradiation plus nivolumab in patients with operable stage II/III esophageal/gastroesophageal juncti...2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Press Mentions
New Study Combines AI and Multiomics Analysis to Understand Cancer Resistance MechanismsJanuary 10th, 2023- Breakthrough Research from Baylor Scott & White Health Transforms the Future of Cancer CareJuly 29th, 2021
- Study Finds Key Advancement in Care for Esophageal CancerJuly 2nd, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Baylor University Medical CenterDallas, Texas
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ronan-kelly
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
